

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | oligosaccharide catabolic process (GO:0009313) | 7.12735424 |
| 2 | glycosphingolipid catabolic process (GO:0046479) | 6.95279142 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.45588728 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 6.38309691 |
| 5 | synaptic vesicle maturation (GO:0016188) | 6.35980783 |
| 6 | glutamate secretion (GO:0014047) | 6.31318568 |
| 7 | glycolipid catabolic process (GO:0019377) | 6.24326282 |
| 8 | amino sugar catabolic process (GO:0046348) | 5.83664644 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.76657554 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.74346879 |
| 11 | ceramide catabolic process (GO:0046514) | 5.68272604 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.56423625 |
| 13 | locomotory exploration behavior (GO:0035641) | 5.44730041 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.35775239 |
| 15 | vocalization behavior (GO:0071625) | 5.27370851 |
| 16 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.21316858 |
| 17 | neuronal action potential propagation (GO:0019227) | 5.10106756 |
| 18 | protein localization to synapse (GO:0035418) | 5.09936458 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 5.02974954 |
| 20 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.87675568 |
| 21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.76561326 |
| 22 | neuron cell-cell adhesion (GO:0007158) | 4.73118591 |
| 23 | layer formation in cerebral cortex (GO:0021819) | 4.64190991 |
| 24 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.62804491 |
| 25 | exploration behavior (GO:0035640) | 4.53354595 |
| 26 | neurotransmitter secretion (GO:0007269) | 4.51969452 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.39838792 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.31947124 |
| 29 | ganglioside metabolic process (GO:0001573) | 4.29846783 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.22873320 |
| 31 | regulation of cholesterol storage (GO:0010885) | 4.22445914 |
| 32 | sphingolipid catabolic process (GO:0030149) | 4.19952152 |
| 33 | regulation of mononuclear cell migration (GO:0071675) | 4.19377910 |
| 34 | regulation of synapse structural plasticity (GO:0051823) | 4.18236942 |
| 35 | proline transport (GO:0015824) | 4.17375983 |
| 36 | membrane lipid catabolic process (GO:0046466) | 4.11104984 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 4.07776542 |
| 38 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.03660939 |
| 39 | neuron-neuron synaptic transmission (GO:0007270) | 4.00213006 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.98042628 |
| 41 | negative regulation of interleukin-12 production (GO:0032695) | 3.96744546 |
| 42 | dendritic spine morphogenesis (GO:0060997) | 3.95787004 |
| 43 | glutamate receptor signaling pathway (GO:0007215) | 3.92543965 |
| 44 | response to acidic pH (GO:0010447) | 3.87875842 |
| 45 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.87386768 |
| 46 | synaptic vesicle endocytosis (GO:0048488) | 3.85418876 |
| 47 | neuron recognition (GO:0008038) | 3.83138645 |
| 48 | glucosamine-containing compound catabolic process (GO:1901072) | 3.79152031 |
| 49 | regulation of neurotransmitter secretion (GO:0046928) | 3.78542318 |
| 50 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.78412862 |
| 51 | positive regulation of membrane potential (GO:0045838) | 3.71429876 |
| 52 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.70306846 |
| 53 | transferrin transport (GO:0033572) | 3.68898800 |
| 54 | phagosome maturation (GO:0090382) | 3.67437728 |
| 55 | activation of protein kinase A activity (GO:0034199) | 3.66240350 |
| 56 | keratan sulfate catabolic process (GO:0042340) | 3.65961969 |
| 57 | response to thyroid hormone (GO:0097066) | 3.65151590 |
| 58 | regulation of synaptic plasticity (GO:0048167) | 3.62117387 |
| 59 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.61147005 |
| 60 | regulation of postsynaptic membrane potential (GO:0060078) | 3.60820282 |
| 61 | axonal fasciculation (GO:0007413) | 3.59079612 |
| 62 | neurotransmitter transport (GO:0006836) | 3.58950818 |
| 63 | long-term synaptic potentiation (GO:0060291) | 3.58739262 |
| 64 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.57943321 |
| 65 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.57855313 |
| 66 | neutrophil activation involved in immune response (GO:0002283) | 3.57431603 |
| 67 | positive regulation of leukocyte degranulation (GO:0043302) | 3.55863325 |
| 68 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.54092294 |
| 69 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.53804752 |
| 70 | positive regulation of mast cell degranulation (GO:0043306) | 3.53804752 |
| 71 | gamma-aminobutyric acid transport (GO:0015812) | 3.52583073 |
| 72 | regulation of vesicle fusion (GO:0031338) | 3.52251280 |
| 73 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.52048996 |
| 74 | N-acetylneuraminate metabolic process (GO:0006054) | 3.50773934 |
| 75 | long-term memory (GO:0007616) | 3.42951086 |
| 76 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.42538948 |
| 77 | trivalent inorganic cation transport (GO:0072512) | 3.42237954 |
| 78 | ferric iron transport (GO:0015682) | 3.42237954 |
| 79 | positive regulation of neurotransmitter transport (GO:0051590) | 3.39949228 |
| 80 | intracellular pH reduction (GO:0051452) | 3.38286579 |
| 81 | response to peptidoglycan (GO:0032494) | 3.37955489 |
| 82 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.37705512 |
| 83 | regulation of neurotransmitter transport (GO:0051588) | 3.37379949 |
| 84 | cellular potassium ion homeostasis (GO:0030007) | 3.37078064 |
| 85 | postsynaptic membrane organization (GO:0001941) | 3.35731882 |
| 86 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.35631109 |
| 87 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.33494864 |
| 88 | pH reduction (GO:0045851) | 3.31109577 |
| 89 | regulation of neurotransmitter levels (GO:0001505) | 3.30358481 |
| 90 | presynaptic membrane assembly (GO:0097105) | 3.28110612 |
| 91 | cell migration in hindbrain (GO:0021535) | 3.27021321 |
| 92 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.27012148 |
| 93 | negative regulation of dendrite development (GO:2000171) | 3.26800477 |
| 94 | regulation of dendritic spine development (GO:0060998) | 3.24420618 |
| 95 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.24247474 |
| 96 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.24247474 |
| 97 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.24143367 |
| 98 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.23836909 |
| 99 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.21870885 |
| 100 | osteoclast differentiation (GO:0030316) | 3.21498776 |
| 101 | response to magnesium ion (GO:0032026) | 3.21283939 |
| 102 | neuromuscular process controlling balance (GO:0050885) | 3.21060576 |
| 103 | response to lipoprotein particle (GO:0055094) | 3.19677300 |
| 104 | positive regulation of synapse maturation (GO:0090129) | 3.18304585 |
| 105 | positive regulation of bone resorption (GO:0045780) | 3.16565949 |
| 106 | positive regulation of bone remodeling (GO:0046852) | 3.16565949 |
| 107 | vesicle transport along microtubule (GO:0047496) | 3.15033471 |
| 108 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.12733592 |
| 109 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.11437004 |
| 110 | membrane depolarization (GO:0051899) | 3.10451568 |
| 111 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.10067380 |
| 112 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07950387 |
| 113 | dendrite morphogenesis (GO:0048813) | 3.07186757 |
| 114 | regulation of glutamate secretion (GO:0014048) | 3.07044282 |
| 115 | positive regulation of mast cell activation (GO:0033005) | 3.06739143 |
| 116 | presynaptic membrane organization (GO:0097090) | 3.06137764 |
| 117 | macrophage activation involved in immune response (GO:0002281) | 3.04921938 |
| 118 | peptide catabolic process (GO:0043171) | 3.04904202 |
| 119 | organelle transport along microtubule (GO:0072384) | 3.04117444 |
| 120 | establishment of synaptic vesicle localization (GO:0097480) | 3.04012430 |
| 121 | synaptic vesicle transport (GO:0048489) | 3.04012430 |
| 122 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.03388075 |
| 123 | apoptotic cell clearance (GO:0043277) | 3.01855665 |
| 124 | monocyte chemotaxis (GO:0002548) | 3.01267416 |
| 125 | innervation (GO:0060384) | 2.99866922 |
| 126 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.99861267 |
| 127 | regulation of synaptic transmission (GO:0050804) | 2.99312289 |
| 128 | synaptic transmission (GO:0007268) | 2.99013391 |
| 129 | membrane depolarization during action potential (GO:0086010) | 2.98148469 |
| 130 | transmission of nerve impulse (GO:0019226) | 2.97771858 |
| 131 | negative regulation of microtubule polymerization (GO:0031115) | 2.97371809 |
| 132 | myeloid dendritic cell differentiation (GO:0043011) | 2.96763088 |
| 133 | synapse assembly (GO:0007416) | 2.96477793 |
| 134 | positive regulation of dendritic spine development (GO:0060999) | 2.96434937 |
| 135 | response to histamine (GO:0034776) | 2.95583778 |
| 136 | behavioral response to cocaine (GO:0048148) | 2.95478278 |
| 137 | positive regulation of synaptic transmission (GO:0050806) | 2.94808077 |
| 138 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.94596029 |
| 139 | detection of calcium ion (GO:0005513) | 2.92591281 |
| 140 | response to auditory stimulus (GO:0010996) | 2.91367796 |
| 141 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.90912470 |
| 142 | bone resorption (GO:0045453) | 2.89335005 |
| 143 | calcium ion-dependent exocytosis (GO:0017156) | 2.88896780 |
| 144 | sodium ion export (GO:0071436) | 2.88886436 |
| 145 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.88856217 |
| 146 | iron ion transport (GO:0006826) | 2.87456012 |
| 147 | dendritic spine organization (GO:0097061) | 2.87128404 |
| 148 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.86397094 |
| 149 | membrane hyperpolarization (GO:0060081) | 2.86160518 |
| 150 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.85518927 |
| 151 | social behavior (GO:0035176) | 2.85202617 |
| 152 | intraspecies interaction between organisms (GO:0051703) | 2.85202617 |
| 153 | positive regulation of cholesterol efflux (GO:0010875) | 2.84666777 |
| 154 | lysosome organization (GO:0007040) | 2.82196534 |
| 155 | lytic vacuole organization (GO:0080171) | 2.82196534 |
| 156 | iron ion import (GO:0097286) | 2.81905235 |
| 157 | negative regulation of lipid storage (GO:0010888) | 2.81217063 |
| 158 | adhesion of symbiont to host cell (GO:0044650) | 2.79983094 |
| 159 | virion attachment to host cell (GO:0019062) | 2.79983094 |
| 160 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.79228692 |
| 161 | positive regulation of osteoclast differentiation (GO:0045672) | 2.77549377 |
| 162 | vitamin D metabolic process (GO:0042359) | 2.77438991 |
| 163 | regulation of mast cell degranulation (GO:0043304) | 2.73647188 |
| 164 | barbed-end actin filament capping (GO:0051016) | 2.70604302 |
| 165 | regulation of monocyte differentiation (GO:0045655) | 2.70434549 |
| 166 | immunoglobulin mediated immune response (GO:0016064) | 2.69972583 |
| 167 | regulation of monocyte chemotaxis (GO:0090025) | 2.69327568 |
| 168 | negative regulation of amino acid transport (GO:0051956) | 2.69120448 |
| 169 | granulocyte activation (GO:0036230) | 2.67549832 |
| 170 | cellular extravasation (GO:0045123) | 2.66056088 |
| 171 | cellular response to arsenic-containing substance (GO:0071243) | 2.65623888 |
| 172 | regulation of leukocyte degranulation (GO:0043300) | 2.64243746 |
| 173 | positive regulation of heat generation (GO:0031652) | 2.63123430 |
| 174 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.62618724 |
| 175 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.61804481 |
| 176 | lipid storage (GO:0019915) | 2.60755610 |
| 177 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.60258528 |
| 178 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.59672593 |
| 179 | cellular iron ion homeostasis (GO:0006879) | 2.58098989 |
| 180 | glycosphingolipid metabolic process (GO:0006687) | 2.58027695 |
| 181 | positive regulation of tissue remodeling (GO:0034105) | 2.55616578 |
| 182 | L-amino acid import (GO:0043092) | 2.54040720 |
| 183 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.53506884 |
| 184 | T-helper 1 type immune response (GO:0042088) | 2.51636238 |
| 185 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.51594762 |
| 186 | adhesion of symbiont to host (GO:0044406) | 2.50881942 |
| 187 | regulation of macrophage chemotaxis (GO:0010758) | 2.49600419 |
| 188 | protein localization to endosome (GO:0036010) | 2.48447005 |
| 189 | sphingosine metabolic process (GO:0006670) | 2.47878212 |
| 190 | myeloid dendritic cell activation (GO:0001773) | 2.47114333 |
| 191 | regulation of superoxide anion generation (GO:0032928) | 2.46727877 |
| 192 | positive regulation of cholesterol transport (GO:0032376) | 2.46025052 |
| 193 | positive regulation of sterol transport (GO:0032373) | 2.46025052 |
| 194 | neuromuscular process controlling posture (GO:0050884) | 2.43694209 |
| 195 | fructose metabolic process (GO:0006000) | 2.42339178 |
| 196 | positive regulation of regulated secretory pathway (GO:1903307) | 2.39257638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.41587366 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.58574497 |
| 3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.78142729 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.57957306 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.53582693 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.52969281 |
| 7 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.32182689 |
| 8 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.25107819 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.16720943 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15717573 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.10564434 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.06435624 |
| 13 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.85966962 |
| 14 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.84840873 |
| 15 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.84840873 |
| 16 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.80206263 |
| 17 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.72962304 |
| 18 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72241606 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.64194797 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.61261995 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.59293251 |
| 22 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.59168993 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57697975 |
| 24 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.57532671 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56084163 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.39015019 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.33212606 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.32302237 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.28386184 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.24083358 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.22774412 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21740966 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.21557726 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18348177 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.18029944 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.12446702 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.11505351 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.02366063 |
| 39 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91618978 |
| 40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.90655504 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87757685 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.86533930 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85844124 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75713685 |
| 45 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75682975 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75458510 |
| 47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.74757572 |
| 48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74564410 |
| 49 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.74080723 |
| 50 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.73167348 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65587024 |
| 52 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64863431 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62697034 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56768160 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.55827781 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53074180 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52167420 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52118683 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45758539 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45587398 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45363017 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42883471 |
| 63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41615398 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41460019 |
| 65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.39631051 |
| 66 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39474705 |
| 67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39271192 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39010440 |
| 69 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38996238 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38353685 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37931182 |
| 72 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36690854 |
| 73 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35885689 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35343913 |
| 75 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33798038 |
| 76 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32692289 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31733025 |
| 78 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31492128 |
| 79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30948422 |
| 80 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30375386 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29829113 |
| 82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29579418 |
| 83 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29025423 |
| 84 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.28724469 |
| 85 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.27444576 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27146035 |
| 87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26354954 |
| 88 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.25128167 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24613321 |
| 90 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24474102 |
| 91 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23020675 |
| 92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22318744 |
| 93 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20435121 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.20307864 |
| 95 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16377262 |
| 96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16351896 |
| 97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16308629 |
| 98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16066956 |
| 99 | AR_19668381_ChIP-Seq_PC3_Human | 1.15959003 |
| 100 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15641255 |
| 101 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15377154 |
| 102 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14900011 |
| 103 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.14209774 |
| 104 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14023977 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12630156 |
| 106 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11657762 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11089228 |
| 108 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10617933 |
| 109 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09724530 |
| 110 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09035659 |
| 111 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08990446 |
| 112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08670759 |
| 113 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08485848 |
| 114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08349773 |
| 115 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08184599 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07532178 |
| 117 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07083643 |
| 118 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06844919 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06576426 |
| 120 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05922163 |
| 121 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05781112 |
| 122 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03617099 |
| 123 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02976494 |
| 124 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01708486 |
| 125 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00153157 |
| 126 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00104548 |
| 127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99954297 |
| 128 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99709028 |
| 129 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99515916 |
| 130 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99334269 |
| 131 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99282142 |
| 132 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98845851 |
| 133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98634790 |
| 134 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97810414 |
| 135 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97305691 |
| 136 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96967599 |
| 137 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.95820188 |
| 138 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95735495 |
| 139 | JUN_21703547_ChIP-Seq_K562_Human | 0.95575115 |
| 140 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95318974 |
| 141 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94530411 |
| 142 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93626282 |
| 143 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93500234 |
| 144 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93042549 |
| 145 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92430067 |
| 146 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91862714 |
| 147 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91862714 |
| 148 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91578097 |
| 149 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90420375 |
| 150 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90362934 |
| 151 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90352603 |
| 152 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88033357 |
| 153 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86417874 |
| 154 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86300308 |
| 155 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86246780 |
| 156 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.86135889 |
| 157 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86089667 |
| 158 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86021743 |
| 159 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85932065 |
| 160 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.85259889 |
| 161 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85182356 |
| 162 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85168881 |
| 163 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84996134 |
| 164 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.84871761 |
| 165 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84413033 |
| 166 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82264896 |
| 167 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.81934556 |
| 168 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80460283 |
| 169 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.75376649 |
| 170 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74136411 |
| 171 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.72752575 |
| 172 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72211502 |
| 173 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71623034 |
| 174 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71623034 |
| 175 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71506268 |
| 176 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70909840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.71839547 |
| 2 | MP0005058_abnormal_lysosome_morphology | 5.17020404 |
| 3 | MP0003880_abnormal_central_pattern | 4.86350995 |
| 4 | MP0003172_abnormal_lysosome_physiology | 4.62835898 |
| 5 | MP0009840_abnormal_foam_cell | 4.37189786 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 4.30653687 |
| 7 | MP0004270_analgesia | 4.19792359 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.58748328 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.46862429 |
| 10 | MP0009745_abnormal_behavioral_response | 3.42167657 |
| 11 | MP0003303_peritoneal_inflammation | 3.31607632 |
| 12 | MP0006082_CNS_inflammation | 3.28494981 |
| 13 | MP0002064_seizures | 3.25953358 |
| 14 | MP0009046_muscle_twitch | 3.13645796 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.99645712 |
| 16 | MP0002736_abnormal_nociception_after | 2.95879712 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.87898780 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.74598801 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 2.71065995 |
| 20 | MP0001486_abnormal_startle_reflex | 2.70445344 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.64429168 |
| 22 | MP0003724_increased_susceptibility_to | 2.59660887 |
| 23 | MP0002272_abnormal_nervous_system | 2.52325626 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.51585114 |
| 25 | MP0002735_abnormal_chemical_nociception | 2.37372354 |
| 26 | MP0002733_abnormal_thermal_nociception | 2.36960902 |
| 27 | MP0000343_altered_response_to | 2.27745746 |
| 28 | MP0001440_abnormal_grooming_behavior | 2.21977976 |
| 29 | MP0002419_abnormal_innate_immunity | 2.19855997 |
| 30 | MP0001970_abnormal_pain_threshold | 2.19078792 |
| 31 | MP0003436_decreased_susceptibility_to | 2.18007526 |
| 32 | MP0004858_abnormal_nervous_system | 2.09321865 |
| 33 | MP0003329_amyloid_beta_deposits | 2.06872347 |
| 34 | MP0005671_abnormal_response_to | 2.03507206 |
| 35 | MP0002067_abnormal_sensory_capabilities | 2.02449885 |
| 36 | MP0001501_abnormal_sleep_pattern | 2.01717588 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.97348476 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.93724286 |
| 39 | MP0000778_abnormal_nervous_system | 1.92831254 |
| 40 | MP0004811_abnormal_neuron_physiology | 1.91916934 |
| 41 | MP0001835_abnormal_antigen_presentation | 1.87852275 |
| 42 | MP0005310_abnormal_salivary_gland | 1.87258628 |
| 43 | MP0002822_catalepsy | 1.84947502 |
| 44 | MP0002184_abnormal_innervation | 1.84388177 |
| 45 | MP0004924_abnormal_behavior | 1.79635802 |
| 46 | MP0005386_behavior/neurological_phenoty | 1.79635802 |
| 47 | MP0008569_lethality_at_weaning | 1.79376347 |
| 48 | MP0003879_abnormal_hair_cell | 1.78550602 |
| 49 | MP0002557_abnormal_social/conspecific_i | 1.74662224 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.71149161 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.68147094 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.67510768 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.66311293 |
| 54 | MP0000955_abnormal_spinal_cord | 1.64638496 |
| 55 | MP0009764_decreased_sensitivity_to | 1.64349604 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.55359645 |
| 57 | MP0005451_abnormal_body_composition | 1.54910746 |
| 58 | MP0009785_altered_susceptibility_to | 1.54783011 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.52564883 |
| 60 | MP0005025_abnormal_response_to | 1.51498059 |
| 61 | MP0001984_abnormal_olfaction | 1.47771725 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.47564345 |
| 63 | MP0002066_abnormal_motor_capabilities/c | 1.47369322 |
| 64 | MP0002882_abnormal_neuron_morphology | 1.43659675 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.40080837 |
| 66 | MP0001790_abnormal_immune_system | 1.39286618 |
| 67 | MP0005387_immune_system_phenotype | 1.39286618 |
| 68 | MP0001905_abnormal_dopamine_level | 1.38530250 |
| 69 | MP0003787_abnormal_imprinting | 1.35275199 |
| 70 | MP0003633_abnormal_nervous_system | 1.34216161 |
| 71 | MP0002723_abnormal_immune_serum | 1.29908526 |
| 72 | MP0005365_abnormal_bile_salt | 1.29032756 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 1.26164517 |
| 74 | MP0005646_abnormal_pituitary_gland | 1.25337229 |
| 75 | MP0004142_abnormal_muscle_tone | 1.23738188 |
| 76 | MP0001845_abnormal_inflammatory_respons | 1.18884460 |
| 77 | MP0003631_nervous_system_phenotype | 1.18001185 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 1.17343181 |
| 79 | MP0001853_heart_inflammation | 1.15714350 |
| 80 | MP0001529_abnormal_vocalization | 1.15576628 |
| 81 | MP0001502_abnormal_circadian_rhythm | 1.15450228 |
| 82 | MP0000751_myopathy | 1.15360640 |
| 83 | MP0005166_decreased_susceptibility_to | 1.14800296 |
| 84 | MP0003448_altered_tumor_morphology | 1.12391241 |
| 85 | MP0002152_abnormal_brain_morphology | 1.10664148 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 1.08151823 |
| 87 | MP0005647_abnormal_sex_gland | 1.07773910 |
| 88 | MP0005410_abnormal_fertilization | 1.04923243 |
| 89 | MP0004885_abnormal_endolymph | 1.04482372 |
| 90 | MP0008872_abnormal_physiological_respon | 1.04471740 |
| 91 | MP0002420_abnormal_adaptive_immunity | 1.04209964 |
| 92 | MP0001800_abnormal_humoral_immune | 1.03654719 |
| 93 | MP0008874_decreased_physiological_sensi | 1.02597809 |
| 94 | MP0000569_abnormal_digit_pigmentation | 1.02331702 |
| 95 | MP0001819_abnormal_immune_cell | 1.02149702 |
| 96 | MP0004019_abnormal_vitamin_homeostasis | 1.01158439 |
| 97 | MP0002837_dystrophic_cardiac_calcinosis | 0.98353267 |
| 98 | MP0008469_abnormal_protein_level | 0.96582217 |
| 99 | MP0000604_amyloidosis | 0.96250240 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.95326675 |
| 101 | MP0003950_abnormal_plasma_membrane | 0.92231466 |
| 102 | MP0002069_abnormal_eating/drinking_beha | 0.92111781 |
| 103 | MP0004947_skin_inflammation | 0.91899263 |
| 104 | MP0004145_abnormal_muscle_electrophysio | 0.91543797 |
| 105 | MP0008260_abnormal_autophagy | 0.91299231 |
| 106 | MP0002229_neurodegeneration | 0.91037520 |
| 107 | MP0002405_respiratory_system_inflammati | 0.89565314 |
| 108 | MP0001188_hyperpigmentation | 0.88203805 |
| 109 | MP0004742_abnormal_vestibular_system | 0.85759929 |
| 110 | MP0006054_spinal_hemorrhage | 0.84274500 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 0.84086845 |
| 112 | MP0003122_maternal_imprinting | 0.83208710 |
| 113 | MP0004085_abnormal_heartbeat | 0.83188993 |
| 114 | MP0005535_abnormal_body_temperature | 0.82505844 |
| 115 | MP0003632_abnormal_nervous_system | 0.81355261 |
| 116 | MP0002090_abnormal_vision | 0.80801602 |
| 117 | MP0005394_taste/olfaction_phenotype | 0.80069282 |
| 118 | MP0005499_abnormal_olfactory_system | 0.80069282 |
| 119 | MP0001963_abnormal_hearing_physiology | 0.79652383 |
| 120 | MP0001664_abnormal_digestion | 0.77305407 |
| 121 | MP0000371_diluted_coat_color | 0.76537359 |
| 122 | MP0000685_abnormal_immune_system | 0.76433062 |
| 123 | MP0003075_altered_response_to | 0.76281285 |
| 124 | MP0003634_abnormal_glial_cell | 0.75842968 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.75540098 |
| 126 | MP0004484_altered_response_of | 0.75341641 |
| 127 | MP0000920_abnormal_myelination | 0.74755422 |
| 128 | MP0005623_abnormal_meninges_morphology | 0.74058450 |
| 129 | MP0002254_reproductive_system_inflammat | 0.73366411 |
| 130 | MP0002752_abnormal_somatic_nervous | 0.73141087 |
| 131 | MP0005165_increased_susceptibility_to | 0.72625865 |
| 132 | MP0010234_abnormal_vibrissa_follicle | 0.71071861 |
| 133 | MP0005397_hematopoietic_system_phenotyp | 0.70149845 |
| 134 | MP0001545_abnormal_hematopoietic_system | 0.70149845 |
| 135 | MP0004510_myositis | 0.70036118 |
| 136 | MP0005464_abnormal_platelet_physiology | 0.70018183 |
| 137 | MP0004215_abnormal_myocardial_fiber | 0.70003043 |
| 138 | MP0002876_abnormal_thyroid_physiology | 0.69110188 |
| 139 | MP0000631_abnormal_neuroendocrine_gland | 0.68818388 |
| 140 | MP0005551_abnormal_eye_electrophysiolog | 0.67948321 |
| 141 | MP0001727_abnormal_embryo_implantation | 0.67711572 |
| 142 | MP0001177_atelectasis | 0.66665022 |
| 143 | MP0002653_abnormal_ependyma_morphology | 0.65274346 |
| 144 | MP0000013_abnormal_adipose_tissue | 0.64437685 |
| 145 | MP0005187_abnormal_penis_morphology | 0.62960351 |
| 146 | MP0000747_muscle_weakness | 0.62673782 |
| 147 | MP0004233_abnormal_muscle_weight | 0.61459351 |
| 148 | MP0003183_abnormal_peptide_metabolism | 0.61438619 |
| 149 | MP0000858_altered_metastatic_potential | 0.59469877 |
| 150 | MP0008961_abnormal_basal_metabolism | 0.58275051 |
| 151 | MP0001348_abnormal_lacrimal_gland | 0.57756852 |
| 152 | MP0003690_abnormal_glial_cell | 0.57400377 |
| 153 | MP0010386_abnormal_urinary_bladder | 0.57342498 |
| 154 | MP0003283_abnormal_digestive_organ | 0.56958804 |
| 155 | MP0003861_abnormal_nervous_system | 0.55408862 |
| 156 | MP0001943_abnormal_respiration | 0.54420732 |
| 157 | MP0010769_abnormal_survival | 0.53537702 |
| 158 | MP0001485_abnormal_pinna_reflex | 0.52933000 |
| 159 | MP0010770_preweaning_lethality | 0.51978913 |
| 160 | MP0002082_postnatal_lethality | 0.51978913 |
| 161 | MP0008004_abnormal_stomach_pH | 0.51517593 |
| 162 | MP0003956_abnormal_body_size | 0.51182116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.66924872 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 7.37408715 |
| 3 | Myokymia (HP:0002411) | 7.10029373 |
| 4 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 6.09821694 |
| 5 | Focal seizures (HP:0007359) | 6.07590156 |
| 6 | Visual hallucinations (HP:0002367) | 5.83536379 |
| 7 | Atonic seizures (HP:0010819) | 5.23908404 |
| 8 | Epileptic encephalopathy (HP:0200134) | 5.13101117 |
| 9 | Disinhibition (HP:0000734) | 5.08429247 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 4.99246216 |
| 11 | Loss of speech (HP:0002371) | 4.89830929 |
| 12 | Febrile seizures (HP:0002373) | 4.64988973 |
| 13 | Dysostosis multiplex (HP:0000943) | 4.51707505 |
| 14 | Absence seizures (HP:0002121) | 4.39942411 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 4.28125920 |
| 16 | Apathy (HP:0000741) | 4.23233363 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 4.15245118 |
| 18 | Diminished motivation (HP:0000745) | 4.07575051 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 4.00642713 |
| 20 | Neuronal loss in central nervous system (HP:0002529) | 3.97299792 |
| 21 | Dialeptic seizures (HP:0011146) | 3.96364659 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.94815889 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.82954062 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.82954062 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.82954062 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 3.75840460 |
| 27 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.66478640 |
| 28 | Broad-based gait (HP:0002136) | 3.58747095 |
| 29 | Ankle clonus (HP:0011448) | 3.57812448 |
| 30 | Poor eye contact (HP:0000817) | 3.57616714 |
| 31 | Action tremor (HP:0002345) | 3.54861175 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.48902742 |
| 33 | Mucopolysacchariduria (HP:0008155) | 3.48902742 |
| 34 | Papilledema (HP:0001085) | 3.41353451 |
| 35 | Amblyopia (HP:0000646) | 3.39819064 |
| 36 | Axonal loss (HP:0003447) | 3.32432297 |
| 37 | Hyperventilation (HP:0002883) | 3.29693609 |
| 38 | Nuclear cataract (HP:0100018) | 3.25167871 |
| 39 | Termporal pattern (HP:0011008) | 3.24720547 |
| 40 | Insidious onset (HP:0003587) | 3.24720547 |
| 41 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.23537849 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 3.23474531 |
| 43 | Gaze-evoked nystagmus (HP:0000640) | 3.22223244 |
| 44 | Urinary urgency (HP:0000012) | 3.20121149 |
| 45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.18830755 |
| 46 | Mutism (HP:0002300) | 3.16663287 |
| 47 | Impaired social interactions (HP:0000735) | 3.11574087 |
| 48 | Abnormal social behavior (HP:0012433) | 3.11574087 |
| 49 | Retinal atrophy (HP:0001105) | 3.10134080 |
| 50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.07543015 |
| 51 | Depression (HP:0000716) | 3.05904068 |
| 52 | Truncal ataxia (HP:0002078) | 2.95494597 |
| 53 | Glomerulonephritis (HP:0000099) | 2.94230354 |
| 54 | Abnormal eating behavior (HP:0100738) | 2.93761422 |
| 55 | Abnormality of the periventricular white matter (HP:0002518) | 2.91446321 |
| 56 | Postural instability (HP:0002172) | 2.91388635 |
| 57 | Dysmetria (HP:0001310) | 2.88606651 |
| 58 | Agnosia (HP:0010524) | 2.86860295 |
| 59 | Dementia (HP:0000726) | 2.83452873 |
| 60 | Myocardial infarction (HP:0001658) | 2.83043368 |
| 61 | Cerebral inclusion bodies (HP:0100314) | 2.81055988 |
| 62 | Anxiety (HP:0000739) | 2.77300129 |
| 63 | Dysdiadochokinesis (HP:0002075) | 2.76050872 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75256026 |
| 65 | Torticollis (HP:0000473) | 2.69613173 |
| 66 | Spastic gait (HP:0002064) | 2.66057417 |
| 67 | Abnormality of the corticospinal tract (HP:0002492) | 2.64384277 |
| 68 | Drooling (HP:0002307) | 2.63454411 |
| 69 | Excessive salivation (HP:0003781) | 2.63454411 |
| 70 | Global brain atrophy (HP:0002283) | 2.61378965 |
| 71 | Complement deficiency (HP:0004431) | 2.60652364 |
| 72 | Upper motor neuron abnormality (HP:0002127) | 2.60118469 |
| 73 | Epileptiform EEG discharges (HP:0011182) | 2.59341470 |
| 74 | Limb dystonia (HP:0002451) | 2.57924423 |
| 75 | Absent speech (HP:0001344) | 2.57824361 |
| 76 | Bradykinesia (HP:0002067) | 2.57388694 |
| 77 | Impaired smooth pursuit (HP:0007772) | 2.56736128 |
| 78 | Progressive neurologic deterioration (HP:0002344) | 2.55344135 |
| 79 | Abnormality of binocular vision (HP:0011514) | 2.53885308 |
| 80 | Diplopia (HP:0000651) | 2.53885308 |
| 81 | Focal dystonia (HP:0004373) | 2.53369242 |
| 82 | EEG with generalized epileptiform discharges (HP:0011198) | 2.51783282 |
| 83 | Impaired vibratory sensation (HP:0002495) | 2.51665103 |
| 84 | Scanning speech (HP:0002168) | 2.51642044 |
| 85 | Pheochromocytoma (HP:0002666) | 2.50856217 |
| 86 | Genetic anticipation (HP:0003743) | 2.47901622 |
| 87 | Progressive inability to walk (HP:0002505) | 2.47771615 |
| 88 | Stereotypic behavior (HP:0000733) | 2.45790731 |
| 89 | Recurrent bacterial skin infections (HP:0005406) | 2.44121596 |
| 90 | Inability to walk (HP:0002540) | 2.43916476 |
| 91 | Personality changes (HP:0000751) | 2.42547807 |
| 92 | Abnormality of the lower motor neuron (HP:0002366) | 2.42091619 |
| 93 | Fetal akinesia sequence (HP:0001989) | 2.42075972 |
| 94 | Polyphagia (HP:0002591) | 2.40959890 |
| 95 | Resting tremor (HP:0002322) | 2.39309010 |
| 96 | Neurofibrillary tangles (HP:0002185) | 2.39215297 |
| 97 | Hypsarrhythmia (HP:0002521) | 2.38659655 |
| 98 | Purpura (HP:0000979) | 2.36396036 |
| 99 | Eczematoid dermatitis (HP:0000976) | 2.30464553 |
| 100 | Megalencephaly (HP:0001355) | 2.27756811 |
| 101 | Craniofacial dystonia (HP:0012179) | 2.27107428 |
| 102 | Hemiparesis (HP:0001269) | 2.25691410 |
| 103 | Neuroendocrine neoplasm (HP:0100634) | 2.22998375 |
| 104 | Status epilepticus (HP:0002133) | 2.22773994 |
| 105 | Prolonged neonatal jaundice (HP:0006579) | 2.22391538 |
| 106 | Generalized myoclonic seizures (HP:0002123) | 2.20698103 |
| 107 | Lower limb muscle weakness (HP:0007340) | 2.20470354 |
| 108 | Delusions (HP:0000746) | 2.19626862 |
| 109 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.19208065 |
| 110 | Metaphyseal irregularity (HP:0003025) | 2.17708106 |
| 111 | Akinesia (HP:0002304) | 2.17360688 |
| 112 | Dysmetric saccades (HP:0000641) | 2.16964619 |
| 113 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.14785960 |
| 114 | Increased serum ferritin (HP:0003281) | 2.13581212 |
| 115 | Recurrent abscess formation (HP:0002722) | 2.13497275 |
| 116 | Inappropriate behavior (HP:0000719) | 2.11659703 |
| 117 | Increased CSF protein (HP:0002922) | 2.08850751 |
| 118 | Intention tremor (HP:0002080) | 2.07671315 |
| 119 | Obstructive sleep apnea (HP:0002870) | 2.07386686 |
| 120 | Epidermoid cyst (HP:0200040) | 2.05312509 |
| 121 | Asymmetric septal hypertrophy (HP:0001670) | 2.01855221 |
| 122 | Amyotrophic lateral sclerosis (HP:0007354) | 2.01465175 |
| 123 | Peripheral demyelination (HP:0011096) | 2.01456823 |
| 124 | Abnormality of glycolipid metabolism (HP:0010969) | 10.8104469 |
| 125 | Abnormality of liposaccharide metabolism (HP:0010968) | 10.8104469 |
| 126 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 10.8104469 |
| 127 | Blue irides (HP:0000635) | 1.99170506 |
| 128 | Incomplete penetrance (HP:0003829) | 1.98709724 |
| 129 | Agitation (HP:0000713) | 1.98170237 |
| 130 | Hepatosplenomegaly (HP:0001433) | 1.97787403 |
| 131 | Lower limb amyotrophy (HP:0007210) | 1.97501717 |
| 132 | Memory impairment (HP:0002354) | 1.97335695 |
| 133 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.96875841 |
| 134 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.96875841 |
| 135 | Ventricular fibrillation (HP:0001663) | 1.96005578 |
| 136 | Hemiplegia (HP:0002301) | 1.95460549 |
| 137 | Skin nodule (HP:0200036) | 1.93937160 |
| 138 | Annular pancreas (HP:0001734) | 1.93355710 |
| 139 | Rapidly progressive (HP:0003678) | 1.93350497 |
| 140 | Poor head control (HP:0002421) | 1.91248141 |
| 141 | Hypoventilation (HP:0002791) | 1.90357997 |
| 142 | Pathologic fracture (HP:0002756) | 1.89512970 |
| 143 | Gait ataxia (HP:0002066) | 1.89045171 |
| 144 | Cardiomegaly (HP:0001640) | 1.88666900 |
| 145 | Hyperthyroidism (HP:0000836) | 1.88467692 |
| 146 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.88345590 |
| 147 | Mediastinal lymphadenopathy (HP:0100721) | 1.87389429 |
| 148 | Ankyloglossia (HP:0010296) | 1.87152810 |
| 149 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.85176333 |
| 150 | Hypoplasia of the brainstem (HP:0002365) | 1.85176333 |
| 151 | J-shaped sella turcica (HP:0002680) | 1.83607684 |
| 152 | Bundle branch block (HP:0011710) | 1.82762601 |
| 153 | Clonus (HP:0002169) | 1.82120512 |
| 154 | Intellectual disability, profound (HP:0002187) | 1.81130296 |
| 155 | Abnormality of salivation (HP:0100755) | 1.80994328 |
| 156 | Rigidity (HP:0002063) | 1.80935643 |
| 157 | Abnormality of complement system (HP:0005339) | 1.78170557 |
| 158 | Dysphonia (HP:0001618) | 1.77411554 |
| 159 | Xanthomatosis (HP:0000991) | 1.76503474 |
| 160 | Urinary incontinence (HP:0000020) | 1.75420134 |
| 161 | Peripheral hypomyelination (HP:0007182) | 1.73359645 |
| 162 | Spastic tetraparesis (HP:0001285) | 1.69682252 |
| 163 | Frequent falls (HP:0002359) | 1.68871610 |
| 164 | Multiple enchondromatosis (HP:0005701) | 1.67298113 |
| 165 | Abnormality of iron homeostasis (HP:0011031) | 1.67203632 |
| 166 | Interstitial pulmonary disease (HP:0006530) | 1.66001913 |
| 167 | Stomatitis (HP:0010280) | 1.62693742 |
| 168 | Myoclonus (HP:0001336) | 1.61963348 |
| 169 | Orchitis (HP:0100796) | 1.61815102 |
| 170 | Thoracic kyphosis (HP:0002942) | 1.56592830 |
| 171 | Spinal muscular atrophy (HP:0007269) | 1.54212386 |
| 172 | Amyloidosis (HP:0011034) | 1.54156510 |
| 173 | Basal ganglia calcification (HP:0002135) | 1.52392156 |
| 174 | Nausea (HP:0002018) | 1.50858030 |
| 175 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.50205016 |
| 176 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.49800949 |
| 177 | Beaking of vertebral bodies (HP:0004568) | 1.47261215 |
| 178 | Optic neuritis (HP:0100653) | 1.46436083 |
| 179 | Retrobulbar optic neuritis (HP:0100654) | 1.46436083 |
| 180 | Conjunctival telangiectasia (HP:0000524) | 1.45337304 |
| 181 | Paralysis (HP:0003470) | 1.44564308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.30389631 |
| 2 | EPHA4 | 4.23623281 |
| 3 | MAP3K9 | 4.01133268 |
| 4 | NTRK3 | 3.83318336 |
| 5 | GRK7 | 3.58813938 |
| 6 | BLK | 3.45299011 |
| 7 | MARK1 | 3.30130581 |
| 8 | MAP3K4 | 3.10571712 |
| 9 | DAPK2 | 3.06191936 |
| 10 | MINK1 | 2.81768313 |
| 11 | MAP2K7 | 2.79333660 |
| 12 | RIPK4 | 2.73405398 |
| 13 | ACVR1B | 2.59971209 |
| 14 | MAP3K11 | 2.59284054 |
| 15 | MAP3K12 | 2.48752213 |
| 16 | PAK6 | 2.46016842 |
| 17 | CDK19 | 2.45772922 |
| 18 | DDR2 | 2.32370113 |
| 19 | KSR2 | 2.17254217 |
| 20 | NME2 | 2.16211170 |
| 21 | MAP2K4 | 2.11057649 |
| 22 | MAP3K14 | 2.00394590 |
| 23 | PLK2 | 1.94889797 |
| 24 | MATK | 1.93490431 |
| 25 | DAPK1 | 1.89709929 |
| 26 | PDK2 | 1.88601587 |
| 27 | TAOK2 | 1.87375818 |
| 28 | ABL2 | 1.87312544 |
| 29 | CASK | 1.79168673 |
| 30 | CAMKK1 | 1.72676320 |
| 31 | PRKD3 | 1.63887428 |
| 32 | NTRK2 | 1.62447885 |
| 33 | GRK5 | 1.61293721 |
| 34 | NTRK1 | 1.56876689 |
| 35 | KSR1 | 1.55089719 |
| 36 | LATS2 | 1.53098665 |
| 37 | MAPK13 | 1.52276107 |
| 38 | TBK1 | 1.49719573 |
| 39 | CDK5 | 1.49259391 |
| 40 | TGFBR2 | 1.47213760 |
| 41 | PNCK | 1.44531734 |
| 42 | PIM2 | 1.39171580 |
| 43 | MOS | 1.34901904 |
| 44 | MAP3K2 | 1.32540423 |
| 45 | MAP2K6 | 1.25840060 |
| 46 | CSK | 1.23717540 |
| 47 | ARAF | 1.22485606 |
| 48 | OXSR1 | 1.20892541 |
| 49 | PRKCG | 1.16834417 |
| 50 | MAP3K13 | 1.15685444 |
| 51 | CAMKK2 | 1.15191266 |
| 52 | BMPR2 | 1.11370433 |
| 53 | SIK2 | 1.10034468 |
| 54 | UHMK1 | 1.08713776 |
| 55 | CDC42BPA | 1.08519136 |
| 56 | PRPF4B | 1.08354665 |
| 57 | PHKG2 | 1.08007109 |
| 58 | PHKG1 | 1.08007109 |
| 59 | RIPK1 | 1.06432816 |
| 60 | MAP3K3 | 1.06030199 |
| 61 | ERN1 | 1.06014065 |
| 62 | TNIK | 1.05406485 |
| 63 | IKBKB | 1.04736069 |
| 64 | MAP3K5 | 0.96418749 |
| 65 | CDK18 | 0.94803307 |
| 66 | PTK2B | 0.94154334 |
| 67 | RET | 0.94101050 |
| 68 | FES | 0.93946870 |
| 69 | MAP2K3 | 0.93118759 |
| 70 | TAOK1 | 0.93066987 |
| 71 | CDK15 | 0.92764542 |
| 72 | CDK14 | 0.92296843 |
| 73 | TYRO3 | 0.89832647 |
| 74 | CAMK2A | 0.89184154 |
| 75 | STK38 | 0.88989079 |
| 76 | CAMK1D | 0.88307309 |
| 77 | STK11 | 0.87320021 |
| 78 | ZAP70 | 0.86985513 |
| 79 | CAMK1 | 0.83315248 |
| 80 | CCNB1 | 0.81616317 |
| 81 | TYK2 | 0.81567521 |
| 82 | CDK11A | 0.81401760 |
| 83 | RAF1 | 0.79974402 |
| 84 | CSNK1G2 | 0.78870489 |
| 85 | IRAK2 | 0.76314842 |
| 86 | SYK | 0.76013516 |
| 87 | TXK | 0.75245842 |
| 88 | TESK1 | 0.72389776 |
| 89 | FGR | 0.72235333 |
| 90 | PDK1 | 0.71195049 |
| 91 | PAK3 | 0.70849758 |
| 92 | JAK2 | 0.70145806 |
| 93 | LMTK2 | 0.69975954 |
| 94 | SCYL2 | 0.68337706 |
| 95 | LYN | 0.68277956 |
| 96 | PDPK1 | 0.66799148 |
| 97 | PRKCH | 0.65322358 |
| 98 | DYRK1A | 0.65004501 |
| 99 | JAK1 | 0.63986361 |
| 100 | SGK494 | 0.63865391 |
| 101 | SGK223 | 0.63865391 |
| 102 | RPS6KA2 | 0.62700255 |
| 103 | MAP3K6 | 0.62598804 |
| 104 | DAPK3 | 0.62420191 |
| 105 | MARK3 | 0.57238007 |
| 106 | MARK2 | 0.57144373 |
| 107 | TESK2 | 0.56282370 |
| 108 | NME1 | 0.56046969 |
| 109 | ALK | 0.55819194 |
| 110 | PKN1 | 0.55124020 |
| 111 | SGK1 | 0.54162265 |
| 112 | MAP3K1 | 0.53890477 |
| 113 | MAP2K1 | 0.51469556 |
| 114 | MAPK4 | 0.49514312 |
| 115 | CAMK2B | 0.49002910 |
| 116 | TAOK3 | 0.48838630 |
| 117 | PRKCE | 0.48358791 |
| 118 | CAMK1G | 0.46496635 |
| 119 | EPHA3 | 0.46457704 |
| 120 | PRKCZ | 0.44291255 |
| 121 | MAP4K1 | 0.42256718 |
| 122 | PIM1 | 0.41563259 |
| 123 | PINK1 | 0.41562756 |
| 124 | MAPK12 | 0.40345131 |
| 125 | NEK6 | 0.40291754 |
| 126 | CHUK | 0.38531291 |
| 127 | PDK3 | 0.38479938 |
| 128 | PDK4 | 0.38479938 |
| 129 | ADRBK1 | 0.38210135 |
| 130 | FYN | 0.37164563 |
| 131 | RPS6KA3 | 0.36181497 |
| 132 | GRK6 | 0.35790252 |
| 133 | SGK2 | 0.35757854 |
| 134 | FER | 0.34976204 |
| 135 | CAMK2G | 0.34765982 |
| 136 | LCK | 0.34654215 |
| 137 | LIMK1 | 0.33864543 |
| 138 | ADRBK2 | 0.33829161 |
| 139 | NEK1 | 0.33358384 |
| 140 | CAMK4 | 0.33299724 |
| 141 | ROCK2 | 0.29707222 |
| 142 | BRSK1 | 0.29607463 |
| 143 | MAP3K7 | 0.28553481 |
| 144 | SGK3 | 0.28072764 |
| 145 | MAPK10 | 0.27958931 |
| 146 | FGFR2 | 0.27550611 |
| 147 | BCR | 0.26384350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysosome_Homo sapiens_hsa04142 | 4.59837486 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.94531524 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.82105515 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 3.32172292 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.28365321 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.86662149 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.81387619 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.59356872 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.59316187 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.57888028 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.48254966 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 2.47602131 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 2.47567665 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.43510767 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.32312549 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.21982501 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 2.17251178 |
| 18 | Phagosome_Homo sapiens_hsa04145 | 2.16928414 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16862772 |
| 20 | Asthma_Homo sapiens_hsa05310 | 2.11535980 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 2.11076515 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.00217963 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.98044586 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.92672166 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.89724551 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88224333 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.80139687 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.77144361 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.75220958 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66627533 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64970640 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64408209 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.64212819 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.63933251 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.63930197 |
| 36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63532918 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.63462906 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.59117107 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48489955 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43474786 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43402826 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.41972616 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.40137958 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39294005 |
| 45 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.39077846 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.36300916 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35167529 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.33328516 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.27697875 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26997420 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26943830 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.25911347 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25506410 |
| 54 | Glioma_Homo sapiens_hsa05214 | 1.24946880 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20837388 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20187663 |
| 57 | Axon guidance_Homo sapiens_hsa04360 | 1.18595065 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18165902 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17395646 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16157567 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 1.13623773 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12589968 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11768300 |
| 64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11346218 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10845809 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08766238 |
| 67 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07755338 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07343460 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07066621 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.06229249 |
| 71 | Melanogenesis_Homo sapiens_hsa04916 | 1.04330373 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00241603 |
| 73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98074998 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.93015394 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92388631 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91672844 |
| 77 | * Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90698096 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89607571 |
| 79 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.88995124 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.87820766 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86465298 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.86158703 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84066411 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80657060 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78524321 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76947287 |
| 87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.76785832 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.75849398 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74193199 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73629311 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70513200 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69485453 |
| 93 | Phototransduction_Homo sapiens_hsa04744 | 0.69221483 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67730323 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67586711 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66481730 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64008328 |
| 98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.63261424 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62981841 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62669708 |
| 101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62489117 |
| 102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61004810 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60753887 |
| 104 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59127472 |
| 105 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58399083 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.58029455 |
| 107 | Parkinsons disease_Homo sapiens_hsa05012 | 0.56583146 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56253267 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.55497704 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.55435768 |
| 111 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.55049402 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55036090 |
| 113 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53664163 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53500756 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52735551 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49341805 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.49251814 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48426258 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45824568 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.45436701 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44070715 |
| 122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43959375 |
| 123 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43629769 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43098768 |
| 125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43054309 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42840856 |
| 127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42840089 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42745664 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42165610 |
| 130 | Alcoholism_Homo sapiens_hsa05034 | 0.42074609 |
| 131 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41229438 |
| 132 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41046223 |
| 133 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40126122 |
| 134 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40044659 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39958244 |
| 136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38608373 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | 0.37984691 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.37952726 |
| 139 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37814953 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36735275 |
| 141 | Bile secretion_Homo sapiens_hsa04976 | 0.36504032 |
| 142 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35845585 |
| 143 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35308777 |
| 144 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34470721 |
| 145 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33496964 |
| 146 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31306409 |
| 147 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.31194445 |
| 148 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.31061836 |
| 149 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30812356 |
| 150 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29750438 |
| 151 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.28843509 |
| 152 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.21812089 |

